FAP and coronary artery disorder: Uitte de Willige et al., observed in patients with coronary heart disease that the levels of soluble FAP were significantly correlated with the time between the event and study inclusion, showing decreasing plasma FAP levels with a shorter interval between the cardiovascular event and inclusion in the study [48].